United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Zydus Lifesciences wins FDA approval for Amantadine Capsules, secures 180-day exclusivity Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has achieved a significant regulatory milestone by receiving final… byPallavi MadhirajuAugust 27, 2024